NCM
PHVS icon

NEXTBio Capital Management’s Pharvaris PHVS Stock Holding History

NEXTBio Capital Management’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.74M Buy
+108,055
New +$3.27M 1.72% 17

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

NEXTBio Capital Management's PHVS Position: Q2 2026 in Review

NEXTBio Capital Management opened a new position in Pharvaris (PHVS) in Q2 2026: 108,055 shares worth $3.74M. The stake represents 1.72% of the portfolio and ranks #17 among its holdings.

125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • NEXTBio Capital Management held 108,055 shares of Pharvaris worth $3.74M as of Q2 2026.
  • Pharvaris was a new NEXTBio Capital Management position in Q2 2026.
  • Pharvaris made up 1.72% of NEXTBio Capital Management's portfolio in Q2 2026, its #17 holding.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on NEXTBio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.